<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02236741</url>
  </required_header>
  <id_info>
    <org_study_id>248.672</org_study_id>
    <nct_id>NCT02236741</nct_id>
  </id_info>
  <brief_title>The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia</brief_title>
  <official_title>The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boehringer Ingelheim</source>
  <brief_summary>
    <textblock>
      Study to assess the risk of incident heart failure associated with the use of pramipexole
      compared with other dopamine agonists and additionally, to assess the risk of incident heart
      failure associated with the use of dopamine agonists in comparison with no use of dopamine
      agonist therapy
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of first-time clinical diagnosis of heart failure</measure>
    <time_frame>150 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall rate of heart failure</measure>
    <time_frame>150 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">26814</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>users of anti-parkinsonian drugs</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mirapexin® (Sifrol®)</intervention_name>
    <arm_group_label>users of anti-parkinsonian drugs</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Users of anti-parkinsonian drugs registered with an up-to-standard practice from the United
        Kingdom's General Practice Research Database (GPRD)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients between 40 and 89 years of age who received at least one prescription for
             anti-parkinsonian drugs during the period 1997-2009

        Exclusion Criteria:

          -  Patients with a diagnosis of heart failure or with prescriptions for two or more among
             the digitalis, angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor
             blocker (ARB), and diuretic drug classes prior to cohort entry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <link>
    <url>http://trials.boehringer-ingelheim.com</url>
  </link>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2014</study_first_submitted>
  <study_first_submitted_qc>September 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2014</study_first_posted>
  <last_update_submitted>September 10, 2014</last_update_submitted>
  <last_update_submitted_qc>September 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dopamine</mesh_term>
    <mesh_term>Pramipexole</mesh_term>
    <mesh_term>Dopamine Agonists</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

